Hypothalamic, pituitary and uterine cytoplasmic and nuclear oestrogen receptors and their relationship to the serum concentration of tamoxifen and its metabolite, 4-hydroxytamoxifen, in the ovariectomized rat
- 1 August 1982
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 94 (2) , 167-175
- https://doi.org/10.1677/joe.0.0940167
Abstract
High-affinity oestrogen receptors were measured in the cytosol and nuclei prepared from the hypothalamus, pituitary gland and uterus of the ovariectomized rat up to 16 days after a single dose of tamoxifen or 4-hydroxytamoxifen. Tamoxifen produced a dose-related fall in the concentration of cytosol receptors in the hypothalamus, pituitary gland and uterus. Minimum values were observed after 24 h; cytosol receptor concentrations were restored slowly and only reached expected control values between 4 and 8 days and 2 and 4 days for 7·0 mg/kg and 0·7 mg/kg doses of tamoxifen respectively. The nuclear receptor changes were inversely related to the cytosol receptor changes, except that hypothalamic nuclear receptor concentrations after 0·7 mg tamoxifen/kg were not changed. 4-Hydroxytamoxifen (0·14 mg/kg) depleted cytosol and raised nuclear oestrogen receptors in the pituitary gland and uterus. Receptor concentrations had returned to the expected control values by day 4. Oestrogen receptor concentrations in the hypothalamus were unchanged. The apparent resistance of the receptor system in the hypothalamus to translocation by tamoxifen and 4-hydroxytamoxifen was probably due to the blood–brain barrier since the apparent affinity of tamoxifen for the cytosol receptor was similar for all three tissues (dissociation constant 4 nmol/l). Serum concentrations of tamoxifen and 4-hydroxytamoxifen measured after a single dose of 7·0 mg tamoxifen/kg were maximal after 24 h and undetectable by 4 days, at which time nuclear and cytosol receptor levels were still changed. Concentrations of 4-hydroxy-tamoxifen were approximately one-third those of tamoxifen. The results suggest that the receptor changes after tamoxifen are not simply related to the serum concentration of tamoxifen and its metabolites and that the retention of ligand within the target tissue may be an important determinant.This publication has 12 references indexed in Scilit:
- Modulation of Rat Uterine Steroid Hormone Receptors by Estrogen and AntiestrogenEndocrinology, 1980
- MEASUREMENT OF TAMOXIFEN IN SERUM BY THIN-LAYER DENSITOMETRYJournal of Endocrinology, 1980
- Effects of Estradiol and the Antiestrogen Tamoxifen on Steroid Hormone Receptor Concentration and Nuclear Ribonucleic Acid Polymerase Activities in Rat Uteri*Endocrinology, 1979
- Antiestrogens: Effects of tamoxifen, nafoxidine, and CI-628 on sexual behavior, cytoplasmic receptors, and nuclear binding of estrogenHormones and Behavior, 1979
- Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628).Journal of Biological Chemistry, 1978
- Simple and rapid fluorimetric method for DNA microassayAnalytical Biochemistry, 1977
- A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITYJournal of Endocrinology, 1977
- An exchange assay for estrogen receptors in cell nuclei of the adult rat brainSteroids, 1977
- Estrogen Receptor Translocation and Replenishment by the Antiestrogen TamoxifenEndocrinology, 1977
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951